ePrints

Updated cost-effectiveness analysis of trastuzumab for early breast cancer: a UK perspective considering duration of benefit, long-term toxicity and pattern of recurrence

Lookup NU author(s): Dr Yemi Oluboyede

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Hall PS, Hulme C, McCabe C, Oluboyede Y, Round J, Cameron DA

Publication type: Article

Publication status: Published

Journal: PharmacoEconomics

Year: 2011

Volume: 29

Issue: 5

Pages: 415-432

Print publication date: 01/05/2011

ISSN (print): 1170-7690

ISSN (electronic): 1179-2027

Publisher: Springer

URL: http://dx.doi.org/10.2165/11588340-000000000-00000

DOI: 10.2165/11588340-000000000-00000

Altmetrics

Share